As a new-type foreign trade service provider driven by technological transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials of Ashwagandha Extract and Withanolides from multiple well-known original manufacturers. With over ten years of market experience and technological transformation cooperation with manufacturers, HiSiaddi has rich experience in product compliance issues. Below is a compliance handling case of Ashwagandha Extract by HiSiaddi.
Contact HiSiaddi customer service for more consultation on compliance issues of Ashwagandha Extract products.
Purchaser: Sérénité Nature SAS, a local premium natural dietary brand based in Paris, France. Its products are sold in premium organic supermarkets, private wellness clinics and pharmacy clinics across Paris, focusing on high-end stress relief and sleep-support soft capsules and oral liquids. Raw materials comply with EU EC396 226-item pesticide residues, REACH regulations, France’s ANSES food safety control, LFGB, RASFF early warning control and California Proposition 65. Leaf-sourced Ashwagandha raw materials are prohibited; only standardized 5% rhizome withanolide extract is purchased, with annual procurement volume of 12 tons. Positioned as premium clinic dietary products, the brand rejects low-grade adulterated raw materials and untraceable bulk goods.
The client previously independently contacted two domestic plant extraction factories and placed an initial 3.2-ton order for 5% withanolides. Before shipment after production, five major compliance barriers emerged one after another: ethylene oxide exceeding standards triggering EU RASFF early warnings, mixed Ashwagandha leaf raw materials violating India’s FSSAI new regulations, COA test reports failing to meet French drug administration format requirements, illegal medical efficacy claims on outer packaging touching EU regulatory red lines, and missing Indian medicinal herb origin traceability + DNA species identification documents. France’s ANSES is tightening Ashwagandha market access; unqualified goods will be detained and destroyed upon port arrival, with a single batch value equivalent to 243,000 Euros, halting the brand’s new product launch plan. The manufacturers could only adjust lactone content, lacking familiarity with the latest multi-country EU regulations and Indian raw material access rules, making them unable to complete full-dimensional compliance rectification. The client fully entrusted HiSiaddi Foreign Trade to coordinate compliance remediation and rectification for shipment.
1.
Excessive Fumigation Pesticide Residues Touching EU RASFF Notification Red Line Indian farms used illegal ethylene oxide fumigation for raw material bacteriostasis, with measured ethylene oxide residue at 26.8 mg/kg versus EU limit ≤0.75 mg/kg. Belgium previously issued a full EU regional early warning for similar over-standard products; once shipped, goods risk port detention and full-batch recall via EU-wide notifications.
2.
3.
Mixed Leaf Raw Materials Violating India’s FSSAI and French Market Access New Regulations Factories mixed cheap Ashwagandha leaf extracts with rhizome raw materials during feeding. India’s 2026 new regulations explicitly stipulate only Ashwagandha rhizomes are permitted for dietary raw materials, with leaves prohibited. France’s ANSES simultaneously warned leaf extracts carry liver and kidney toxicity risks, making raw materials unable to pass French import raw material filing.
4.
5.
Test Reports Fail EU Standards, COA Data and Formats Unrecognized by Drug Authorities Manufacturers only issued test certificates per domestic national standards, lacking HPLC withanolide monomer spectra and separate heavy metal/solvent residue breakdowns. The language and item layout of SGS reports fail French drug administration filing specifications, making pre-import filing impossible.
6.
7.
Illegal Efficacy Claims on Outer Packaging Violating EU Food Claim Regulations Packaging bears medical descriptions such as "treat anxiety, improve insomnia". EU dietary regulations prohibit pharmaceutical-style efficacy labeling, leading to outright rejection during French customs label review for customs clearance.
8.
9.
Missing Full-Chain Traceability Documents Lack of Indian planting base GAP filing, official origin certificates, Ashwagandha rhizome/leaf DNA identification reports and India’s AYUSH raw material free sales certificates. French customs require full traceability of herbal raw materials down to field plots; missing documents block customs clearance.
10.
HiSiaddi set up a special task force consisting of EU compliance specialists, plant extraction technical engineers, SGS third-party coordinators and local Indian compliance agents, forming a closed-loop rectification covering raw material traceability replacement → pesticide residue removal via processes → full re-testing of product indicators → label revision → full compliance document compilation.
1. HiSiaddi partnered with licensed AYUSH-compliant planting bases in India to source pure Ashwagandha rhizome raw materials, issuing Indian Ministry of Agriculture origin certificates, GAP field control ledgers and FSSAI compliance certificates. Entrust third-party laboratories to conduct DNA species identification and issue rhizome/leaf ingredient differentiation reports to eliminate leaf adulteration from the raw material source.
2. Return original leaf-adulterated raw materials and re-produce with new feeding; retain full incoming inspection ledgers for all raw materials upon factory arrival.
1. Adopt negative-pressure low-temperature vacuum desorption processes to remove residual ethylene oxide, with post-rectification residue measured <0.3 mg/kg, below EU limits. Optimize extraction sections with three-stage distillation to remove ethanol solvent residues, controlling solvent residue within 300 ppm.
2. Entrust SGS to conduct full screening of 226 pesticide residues per EC396 plus USP heavy metal limit testing to avoid organic phosphorus and heavy metal over-standard risks and prevent RASFF early warnings.
Reissue full English COA reports per French drug administration specifications, attached with original HPLC spectra of withanolides, separate tables of monomer content, heavy metals, solvents and pesticide residues, all data aligned with European Pharmacopoeia EP standards. Documents can be directly used for French import drug administration filing.
Eliminate all medical promotional texts; labels only display compliant structural and functional descriptions: "helps soothe the body and mind, supports physical stress regulation", complying with EU Dietary Supplement Label Regulation 2002/46/EC. Synchronously add warning labels required by France’s ANSES: individuals with thyroid disorders shall consult physicians before consumption, completing revised Chinese-English packaging versions.
Consolidate notarized Indian origin documents, DNA identification reports, factory export food filing qualifications, full SGS test reports, English MSDS safety data sheets and CMC production process files, bind and file in accordance with French customs pre-review catalogs, and submit to French importers in advance for pre-filing of imported raw materials.
Three rounds of samples were sent to French third-party laboratories for re-testing, with all indicators meeting France’s ANSES and EU market access requirements. After rectification, the 3.2-ton products were vacuum foil moisture-proof packaged and shipped, passing Marseille customs with zero inspection and smooth release. Raw materials entered the client’s French GMP formulation workshop for mass production, with all finished batches passing French pharmacy market launch sampling without compliance abnormalities.
The client confirmed the compliance service capacity and signed an annual long-term procurement framework of 12 tons, scheduled for monthly production in 10 batches. Subsequent customized demand for high-end skincare-grade low-pesticide residue refined withanolide raw materials saw HiSiaddi fully entrusted with all raw material compliance pre-review, document handling and export customs clearance. Endorsed by this French high-end brand cooperation, the cooperating manufacturers upgraded EU-standardized compliance production lines with complete LFGB and cGMP qualifications, successively securing orders from two equivalent premium dietary brands in Switzerland and Luxembourg.
Most domestic plant extraction manufacturers focus on production to meet content standards, lacking familiarity with India’s new raw material access regulations, dynamically updated multi-country EU regulations and RASFF early warning control. While European mid-to-high-end dietary brands are proficient in local drug administration rules, they lack understanding of raw material supply chain chaos in China and origin certificate processing procedures in India. Independent direct procurement easily leads to compliance blockages and full-batch cargo losses. Relying on cross-border compliance resources, HiSiaddi connects a full service chain covering overseas raw material compliance traceability, production process compliance rectification, product testing compliance and label customs clearance compliance, helping domestic Ashwagandha Extract stably enter mid-to-high-end European dietary supply chains.
Contact HiSiaddi customer service for more consultation on compliance issues of Ashwagandha Extract products.